Dr. David Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine. Following completion of general and interventional cardiology fellowship at Duke University, he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences.

Dr. Kandzari has also served as Chief Medical Officer for the Cordis Corporation/Johnson & Johnson and as a Medical Officer for the US Food and Drug Administration. Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology.